Eisai
Eisai and its company Morphotek joined the lab to tag the “untaggable”: native chemical tagging of C–H bonds for antibody–drug conjugates. Eisai chemists have since contributed to strategies for C(sp3)-rich complexity and electrochemical C–H fluorination.
Tokyo, Japan · Includes Morphotek, an Eisai company
- Papers together
- 3
- Years
- 2013–2019
- Co-authors
- 11
All 3 papers with Eisai
-
Building C(sp3)-Rich Complexity by Combining Cycloaddition and C–C Cross-Coupling Reactions
- Eisai Francis G. Fang, Hui Fang, Hyeong-wook Choi, Lynn D. Hawkins, Mingde Shan
-
Bioconjugation by Native Chemical Tagging of C–H Bonds
- Eisai Earl F. Albone, Edward M. Suh, Luigi Grasso, Xin Cheng
No papers match these filters.
Our co-authors at Eisai
Earl F. Albone · Xin Cheng · Hyeong-wook Choi · Francis G. Fang · Hui Fang · Luigi Grasso · Lynn D. Hawkins · Tamaki Hoshikawa · Mingde Shan · Tomoyuki Shibuguchi · Edward M. Suh
Some of these papers were shared with 2 other partners: Asymchem, Enamine.
More partners
Enamine
HitGen Hongene Biotech Hongene Biotech IKA IKA InduPro Therapeutics InduPro Therapeutics
KULR Technology RQx Pharmaceuticals RQx Pharmaceuticals Socrates Biosciences Socrates Biosciences The Medicines Company The Medicines Company Interested in collaborating with the Baran lab?
If your team has a problem that matters, a molecule no one can make, a reaction that will not scale, a reagent that should exist, we would love to hear about it.
Email Philor write to pbaran@scripps.edu


